Request Demo
Last update 16 May 2025
Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
Last update 16 May 2025
Overview
Basic Info
Drug Type Tumor necrosis factors |
Synonyms- |
Target |
Action agonists, stimulants |
Mechanism TRAIL receptor agonists, Apoptosis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 651154029
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Lung Non-Small Cell Carcinoma | Phase 3 | China | 01 Oct 2016 | |
| metastatic non-small cell lung cancer | Phase 3 | China | 01 Oct 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT03083743 (Pubmed) Manual  | Phase 3 | 452 | vinorelbine+cisplatin+dulanermin | nwetjgpgbb(sggblhlgxw) = msgnzrexys gdoefygoeq (mkaoeklckm ) View more | Positive | 01 Apr 2018 | |
vinorelbine+cisplatin+Placebo | nwetjgpgbb(sggblhlgxw) = ybcgoxnlob gdoefygoeq (mkaoeklckm ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free